Fentanyl Cit 25mcg/0.5ml Pf Inj

Manufacturer HIKMA PHARMACEUTICALS USA Active Ingredient Fentanyl Injection(FEN ta nil) Pronunciation FEN-ta-nil
WARNING: This is an opioid drug. Opioid drugs can put you at risk for drug use disorder. These can lead to overdose and death. You will be watched closely while taking this drug.Severe breathing problems may happen with this drug. The risk is highest when you first start taking this drug or any time your dose is raised. These breathing problems can be deadly. Call your doctor right away if you have slow, shallow, or trouble breathing. Even one dose of this drug may be deadly if it is taken by someone else or by accident, especially in children. If this drug is taken by someone else or by accident, get medical help right away.Keep all drugs in a safe place. Keep all drugs out of the reach of children and pets.Severe side effects have happened when opioid drugs were used with benzodiazepines, alcohol, marijuana, other forms of cannabis, or street drugs. This includes severe drowsiness, breathing problems, and death. Benzodiazepines include drugs like alprazolam, diazepam, and lorazepam. If you have questions, talk with the doctor.Many drugs interact with this drug and can raise the chance of side effects like deadly breathing problems. Talk with your doctor and pharmacist to make sure it is safe to use this drug with all of your drugs.Get medical help right away if you feel very sleepy, very dizzy, or if you pass out. Caregivers or others need to get medical help right away if the patient does not respond, does not answer or react like normal, or will not wake up.If you are pregnant or plan to get pregnant, talk with your doctor right away about the benefits and risks of using this drug during pregnancy. Using this drug for a long time during pregnancy may lead to withdrawal in the newborn baby. Withdrawal in the newborn can be life-threatening if not treated. @ COMMON USES: It is used to manage pain.
🏷️
Drug Class
Opioid analgesic
🧬
Pharmacologic Class
Opioid agonist
🀰
Pregnancy Category
C
βœ…
FDA Approved
Jun 1968
βš–οΈ
DEA Schedule
Schedule II

Overview

ℹ️

What is this medicine?

Fentanyl is a very strong pain medicine that belongs to a group of drugs called opioids. It works by changing how your brain and nervous system respond to pain. It is used to treat severe pain, often in hospitals or for procedures, and can also be used as part of anesthesia.
πŸ“‹

How to Use This Medicine

To use this medication correctly, follow your doctor's instructions and carefully read all accompanying information. Take this medication exactly as directed, and adhere to all guidelines provided. This medication is administered via injection.

For proper storage and disposal, consult with your doctor, nurse, or pharmacist to determine the best approach if you need to store this medication at home.

If you miss a dose, contact your doctor immediately to receive guidance on the appropriate course of action.
πŸ’‘

Lifestyle & Tips

  • Avoid alcohol and other sedating medications (like tranquilizers, sleeping pills, or other pain medications) unless specifically instructed by your doctor, as this can lead to dangerous breathing problems or extreme drowsiness.
  • Do not drive or operate heavy machinery until you know how this medication affects you, as it can cause dizziness, drowsiness, and impaired judgment.
  • Report any signs of difficulty breathing, extreme sleepiness, or confusion immediately to a healthcare professional.
  • Do not share this medication with anyone else, as it can be fatal if used by someone for whom it was not prescribed.

Dosing & Administration

πŸ‘¨β€βš•οΈ

Adult Dosing

Standard Dose: For acute pain/procedural sedation: 25-100 mcg (0.5-2 mL of 25 mcg/0.5 mL solution) IV/IM, may repeat every 1-2 hours as needed. Dose should be individualized based on patient's weight, age, physical status, underlying pathology, concomitant medications, and type of anesthesia/procedure.
Dose Range: 25 - 100 mg

Condition-Specific Dosing:

acute_pain_analgesia: 25-100 mcg IV/IM, may repeat every 1-2 hours as needed.
anesthesia_adjunct: Initial dose 2-20 mcg/kg IV, maintenance 1-2 mcg/kg IV as needed.
πŸ‘Ά

Pediatric Dosing

Neonatal: Not established for routine use; extreme caution and reduced doses if used (e.g., 0.5-1 mcg/kg IV for procedural sedation, titrate carefully).
Infant: 1-2 mcg/kg IV for sedation/analgesia, titrate carefully. Not recommended for routine use in infants <1 year due to increased risk of respiratory depression.
Child: 1-2 mcg/kg IV for sedation/analgesia, titrate carefully. Max single dose typically 50 mcg.
Adolescent: Similar to adult dosing, 25-100 mcg IV/IM, titrate carefully.
βš•οΈ

Dose Adjustments

Renal Impairment:

Mild: No specific dose adjustment recommended, but monitor closely for increased effects.
Moderate: Consider dose reduction (e.g., 25-50% of usual dose) and extend dosing interval. Monitor closely for respiratory depression.
Severe: Significant dose reduction (e.g., 50-75% of usual dose) and extended dosing interval. Monitor closely for respiratory depression and prolonged effects.
Dialysis: Fentanyl is not significantly removed by dialysis. Administer after dialysis. Monitor closely for prolonged effects.

Hepatic Impairment:

Mild: No specific dose adjustment recommended, but monitor closely.
Moderate: Consider dose reduction (e.g., 25-50% of usual dose) and extend dosing interval due to reduced clearance. Monitor closely for respiratory depression.
Severe: Significant dose reduction (e.g., 50-75% of usual dose) and extended dosing interval. Monitor closely for prolonged effects and respiratory depression.

Pharmacology

πŸ”¬

Mechanism of Action

Fentanyl is a potent, synthetic opioid agonist that primarily interacts with the mu-opioid receptors in the central nervous system (CNS). Its primary therapeutic effects (analgesia and sedation) are mediated through activation of these receptors. Mu-opioid receptors are coupled to G-proteins and their activation leads to inhibition of adenylate cyclase, decreased intracellular cAMP, and modulation of ion channel activity (e.g., opening of potassium channels, inhibition of calcium channels), resulting in hyperpolarization of neurons and inhibition of neurotransmitter release.
πŸ“Š

Pharmacokinetics

Absorption:

Bioavailability: 100% (IV)
Tmax: IV: 3-5 minutes (peak analgesic effect)
FoodEffect: Not applicable for injectable formulation.

Distribution:

Vd: 4 L/kg (adults), 3-5 L/kg (pediatrics)
ProteinBinding: 80-85% (primarily to alpha-1-acid glycoprotein)
CnssPenetration: Yes (rapid and extensive)

Elimination:

HalfLife: Terminal elimination half-life: 3-12 hours (IV, context-sensitive half-time can be longer with prolonged infusions)
Clearance: 0.8-1.2 L/kg/hr
ExcretionRoute: Primarily renal (75% as metabolites, <10% as unchanged drug), fecal (9% as metabolites)
Unchanged: <10%
⏱️

Pharmacodynamics

OnsetOfAction: IV: 30 seconds - 1 minute
PeakEffect: IV: 3-5 minutes
DurationOfAction: IV: 30-60 minutes (single dose)

Safety & Warnings

⚠️

BLACK BOX WARNING

RISK OF ADDICTION, ABUSE, AND MISUSE: Fentanyl exposes patients and other users to the risks of opioid addiction, abuse, and misuse, which can lead to overdose and death. Assess each patient’s risk prior to prescribing Fentanyl, and monitor all patients regularly for the development of these behaviors and conditions.
RESPIRATORY DEPRESSION: Serious, life-threatening, or fatal respiratory depression may occur with use of Fentanyl. Monitor for respiratory depression, especially during initiation of Fentanyl or following a dose increase.
ACCIDENTAL EXPOSURE: Accidental exposure to even a single dose of Fentanyl, especially in children, can result in a fatal overdose.
NEONATAL OPIOID WITHDRAWAL SYNDROME: Prolonged use of Fentanyl during pregnancy can result in neonatal opioid withdrawal syndrome, which may be life-threatening if not recognized and treated, and requires management according to protocols developed by neonatology experts. If opioid use is required for a prolonged period in a pregnant woman, advise the patient of the risk of neonatal opioid withdrawal syndrome and ensure that appropriate treatment will be available.
RISK FROM CONCOMITANT USE WITH BENZODIAZEPINES OR OTHER CNS DEPRESSANTS: Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing of these drugs for use in patients for whom alternative treatment options are inadequate. Limit dosages and durations to the minimum required. Follow patients for signs and symptoms of respiratory depression and sedation.
⚠️

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of low blood sugar, including:
+ Dizziness
+ Headache
+ Feeling sleepy or weak
+ Shaking
+ Fast heartbeat
+ Confusion
+ Hunger
+ Sweating
Severe dizziness or fainting
Confusion
Severe constipation or stomach pain, which may indicate a serious bowel problem
Breathing difficulties, such as:
+ Trouble breathing
+ Slow or shallow breathing
+ Noisy breathing
+ Sleep apnea (breathing problems during sleep)
Chest pain
Abnormal heartbeat (fast or slow)
Seizures
Depression
Trouble controlling body movements
Swelling in the arms or legs
Changes in vision

Serotonin Syndrome: A Potentially Life-Threatening Condition

If you take this medication with certain other drugs, you may be at risk for serotonin syndrome, a severe and potentially deadly condition. Seek medical help immediately if you experience:

Agitation
Balance problems
Confusion
Hallucinations
Fever
Abnormal heartbeat
Flushing
Muscle twitching or stiffness
Seizures
Shivering or shaking
Excessive sweating
Severe diarrhea, nausea, or vomiting
Severe headache

Adrenal Gland Problems: A Rare but Serious Condition

Taking an opioid medication like this one may lead to a rare but severe adrenal gland problem. Contact your doctor right away if you experience:

Extreme fatigue or weakness
Fainting
Severe dizziness
Nausea or vomiting
Decreased appetite

Other Possible Side Effects

While many people may not experience side effects or may only have mild symptoms, it's essential to be aware of the following possible side effects:

Dizziness
Drowsiness
Fatigue
Weakness
Dry mouth
Constipation
Diarrhea
Stomach pain
Nausea or vomiting
Decreased appetite
Headache
Feeling cold
Sleep disturbances
Excessive sweating
Irritation at the site of administration

If you experience any of these side effects or have concerns about other symptoms, contact your doctor for guidance. You can also report side effects to the FDA at 1-800-332-1088 or visit https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Slow or shallow breathing
  • Extreme drowsiness or difficulty waking up
  • Dizziness or lightheadedness
  • Confusion
  • Blue lips or fingernails
  • Pinpoint pupils
  • Severe constipation
πŸ“‹

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following conditions to ensure safe treatment:

Any allergies you have, including allergies to this medication, other medications, foods, or substances. Describe the allergic reaction and its symptoms.
Respiratory problems, such as asthma, breathing difficulties, or sleep apnea.
Elevated carbon dioxide levels in the blood.
Stomach or bowel obstruction or narrowing.
Kidney disease or liver disease.
Recent use (within the last 14 days) of certain medications for depression or Parkinson's disease, including isocarboxazid, phenelzine, tranylcypromine, selegiline, or rasagiline, as this may lead to severely high blood pressure.
* Current use of medications such as buprenorphine, butorphanol, linezolid, methylene blue, nalbuphine, or pentazocine.

This list is not exhaustive, and it is crucial to disclose all your medications (prescription, over-the-counter, natural products, and vitamins) and health issues to your doctor and pharmacist. They will help determine if it is safe to take this medication with your existing health conditions and other medications. Never start, stop, or adjust the dosage of any medication without consulting your doctor first.
⚠️

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

When starting this medication, avoid driving and other activities that require alertness until you understand how it affects you. To minimize the risk of dizziness or fainting, get up slowly from a sitting or lying position, and be cautious when climbing stairs.

Long-term or high-dose use of this medication can lead to tolerance, where the drug becomes less effective, and higher doses may be needed to achieve the same pain relief. If you experience a decrease in the medication's effectiveness, contact your doctor. Do not exceed the prescribed dose.

Prolonged or regular use of opioid medications like this one can cause dependence. Suddenly stopping or reducing the dose can increase the risk of withdrawal or other severe problems. Consult your doctor before changing your dose or stopping the medication, and follow their instructions carefully. Monitor for signs of withdrawal, increased pain, mood changes, suicidal thoughts, or other adverse effects, and report them to your doctor.

Adhere to your doctor's instructions regarding dosage and frequency. Taking more than prescribed, taking it more often, or using it for a longer period can increase the risk of severe side effects.

Do not combine this medication with other strong pain relievers or use a pain patch without consulting your doctor first. If your pain worsens, you experience increased sensitivity to pain, or you develop new pain, contact your doctor immediately. Do not exceed the prescribed dose.

If you consume grapefruit juice or eat grapefruit regularly, discuss this with your doctor. Avoid using this medication with alcohol or products containing alcohol, as this can lead to unsafe and potentially fatal effects.

This medication may increase the risk of seizures, particularly in individuals with a history of seizures. Consult your doctor to determine if you are at a higher risk of seizures while taking this medication.

Long-term use of opioid medications can lead to decreased sex hormone levels. If you experience a decrease in libido, fertility problems, irregular menstrual periods, or ejaculation issues, contact your doctor.

If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.

If you are breastfeeding, inform your doctor, as this medication can pass into breast milk and harm your baby. Seek medical attention immediately if your baby appears excessively sleepy, limp, or has breathing difficulties.
πŸ†˜

Overdose Information

Overdose Symptoms:

  • Severe respiratory depression (slowed or stopped breathing)
  • Extreme somnolence progressing to stupor or coma
  • Pinpoint pupils (miosis)
  • Flaccid skeletal muscle
  • Cold, clammy skin
  • Bradycardia
  • Hypotension
  • Circulatory collapse
  • Death

What to Do:

Seek immediate emergency medical attention. Call 911 or your local emergency number. If available, administer naloxone (Narcan) if the person is unresponsive or has severe breathing problems. Continue to monitor breathing and be prepared to administer more naloxone if needed, as fentanyl's effects can outlast naloxone's. Provide ventilatory support if necessary. Call 1-800-222-1222 (Poison Control) for additional guidance.

Drug Interactions

🚫

Contraindicated Interactions

  • Monoamine Oxidase Inhibitors (MAOIs) within 14 days (risk of severe, unpredictable reactions including serotonin syndrome or hypertensive crisis)
πŸ”΄

Major Interactions

  • Benzodiazepines and other CNS depressants (e.g., other opioids, sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, alcohol): Increased risk of profound sedation, respiratory depression, coma, and death.
  • CYP3A4 inhibitors (e.g., ritonavir, ketoconazole, itraconazole, clarithromycin, erythromycin, grapefruit juice): Increased fentanyl plasma concentrations, leading to prolonged opioid effects and increased risk of respiratory depression.
  • Serotonergic drugs (e.g., SSRIs, SNRIs, TCAs, triptans, mirtazapine, tramadol): Risk of serotonin syndrome.
  • Mixed agonist/antagonist opioids (e.g., pentazocine, nalbuphine, butorphanol): May reduce fentanyl's analgesic effect and/or precipitate withdrawal symptoms.
🟑

Moderate Interactions

  • CYP3A4 inducers (e.g., rifampin, carbamazepine, phenytoin, St. John's Wort): Decreased fentanyl plasma concentrations, potentially leading to reduced efficacy or withdrawal symptoms.
  • Anticholinergic drugs: Increased risk of urinary retention and severe constipation.
🟒

Minor Interactions

  • Not available (most interactions are significant due to fentanyl's potency and narrow therapeutic index)

Monitoring

πŸ”¬

Baseline Monitoring

Respiratory rate and depth

Rationale: To assess baseline respiratory function and identify risk for respiratory depression.

Timing: Prior to administration

Oxygen saturation (SpO2)

Rationale: To assess baseline oxygenation status.

Timing: Prior to administration

Heart rate and blood pressure

Rationale: To assess baseline cardiovascular status; fentanyl can cause bradycardia and hypotension.

Timing: Prior to administration

Level of consciousness/sedation score

Rationale: To establish baseline mental status and assess for excessive sedation.

Timing: Prior to administration

Pain score (if applicable)

Rationale: To establish baseline pain level for efficacy assessment.

Timing: Prior to administration

πŸ“Š

Routine Monitoring

Respiratory rate and depth

Frequency: Every 5-15 minutes initially, then as clinically indicated (e.g., every 1-2 hours) for continuous infusions or prolonged effects.

Target: Typically >10-12 breaths/min (adults), age-appropriate for pediatrics

Action Threshold: <10 breaths/min (adults), significant decrease from baseline, or signs of hypoventilation; administer naloxone, provide ventilatory support.

Oxygen saturation (SpO2)

Frequency: Continuous pulse oximetry during and immediately after administration, then as clinically indicated.

Target: >92-94%

Action Threshold: <90% or significant drop from baseline; administer supplemental oxygen, consider naloxone, provide ventilatory support.

Level of consciousness/sedation score (e.g., Ramsay, RASS)

Frequency: Every 5-15 minutes initially, then as clinically indicated.

Target: Desired level of sedation (e.g., easily aroused)

Action Threshold: Unarousable, excessive sedation (e.g., Ramsay 4-6); consider naloxone, reduce dose, provide ventilatory support.

Heart rate and blood pressure

Frequency: Every 5-15 minutes initially, then as clinically indicated.

Target: Within patient's normal range

Action Threshold: Significant bradycardia or hypotension; manage symptomatically.

Pain score (if applicable)

Frequency: Every 15-30 minutes after administration, then as needed.

Target: Patient-specific pain goal

Action Threshold: Inadequate pain control; consider additional dose or alternative analgesia.

πŸ‘οΈ

Symptom Monitoring

  • Signs of respiratory depression (slow, shallow breathing, cyanosis, somnolence, unresponsiveness)
  • Excessive sedation or somnolence
  • Nausea and vomiting
  • Constipation
  • Pruritus
  • Urinary retention
  • Muscle rigidity (especially truncal rigidity with rapid IV administration)
  • Signs of opioid withdrawal (if abruptly discontinued after prolonged use)

Special Patient Groups

🀰

Pregnancy

Use during pregnancy is generally not recommended unless the potential benefits outweigh the risks. Prolonged use during pregnancy can lead to neonatal opioid withdrawal syndrome (NOWS) in the newborn, which can be life-threatening if not recognized and treated. Fentanyl crosses the placenta.

Trimester-Specific Risks:

First Trimester: Limited data, but potential for congenital malformations with opioid exposure. Risk likely low for single, acute doses.
Second Trimester: Risk of NOWS increases with prolonged exposure. Respiratory depression in the fetus/neonate.
Third Trimester: High risk of NOWS with prolonged exposure. Risk of acute respiratory depression in the neonate if administered close to delivery.
🀱

Lactation

Fentanyl is excreted into breast milk. Due to the potential for serious adverse reactions in breastfed infants (e.g., sedation, respiratory depression), breastfeeding is generally not recommended during treatment with fentanyl. If a single dose is given, monitor the infant closely for signs of sedation or respiratory depression.

Infant Risk: Moderate risk (L3). Potential for sedation, respiratory depression, poor feeding, and withdrawal symptoms in the infant. The American Academy of Pediatrics considers fentanyl to be a drug for which the effect on the nursing infant is unknown but may be of concern.
πŸ‘Ά

Pediatric Use

Fentanyl should be used with extreme caution in pediatric patients due to the increased risk of respiratory depression, especially in infants and very young children. Dosing must be carefully calculated based on weight and titrated to effect. Close monitoring of respiratory status and level of consciousness is essential.

πŸ‘΄

Geriatric Use

Elderly patients may be more sensitive to the effects of fentanyl, particularly respiratory depression, sedation, and constipation, due to decreased hepatic and renal function, reduced lean body mass, and altered pharmacokinetics. Lower initial doses and slower titration are recommended. Monitor closely for adverse effects.

Clinical Information

πŸ’Ž

Clinical Pearls

  • Fentanyl is highly potent; even small errors in dosing can lead to severe respiratory depression or death.
  • Rapid IV administration can cause truncal rigidity, which may impair ventilation. This can be managed with neuromuscular blockers or naloxone.
  • The context-sensitive half-time of fentanyl increases with prolonged infusions, meaning its elimination half-life becomes longer after extended administration, leading to prolonged effects.
  • Always have naloxone readily available when administering fentanyl.
  • Tolerance and physical dependence can develop with repeated administration, even over short periods.
  • Patients receiving fentanyl should be continuously monitored for respiratory depression, especially during the first 24-72 hours after initiation or dose increase.
πŸ”„

Alternative Therapies

  • Other opioid analgesics (e.g., morphine, hydromorphone, oxycodone, sufentanil, remifentanil)
  • Non-opioid analgesics (e.g., NSAIDs, acetaminophen, local anesthetics, regional blocks)
  • Adjuvant analgesics (e.g., gabapentin, pregabalin, ketamine, alpha-2 agonists like clonidine/dexmedetomidine)
πŸ’°

Cost & Coverage

Average Cost: Varies widely by manufacturer, quantity, and contract. For 25mcg/0.5ml single-dose vial, typically a few dollars per vial. per vial
Generic Available: Yes
Insurance Coverage: Generally covered by most insurance plans as a generic injectable, often under medical benefit for inpatient/procedural use.
πŸ“š

General Drug Facts

If your symptoms or health problems do not improve or worsen, it is essential to contact your doctor promptly. To ensure safe use, do not share your medication with others, and never take someone else's medication. Store all medications in a secure location, out of the reach of children and pets, to prevent accidental ingestion.

When disposing of unused doses, follow the instructions provided with the medication. If you have questions or concerns about disposal, consult your pharmacist for guidance. Additionally, some medications may come with a separate patient information leaflet; check with your pharmacist to see if this applies to your medication.

If you have any questions or concerns about your medication, do not hesitate to discuss them with your doctor, nurse, pharmacist, or other healthcare provider. It is also crucial to be aware that an overdose of this medication can be treated with naloxone. Consult your doctor or pharmacist about obtaining and using naloxone, and be prepared to seek immediate medical attention if an overdose is suspected, even if naloxone has been administered.

In the event of a suspected overdose, call your local poison control center or seek emergency medical care right away. When seeking help, be prepared to provide information about the medication taken, the amount, and the time it was taken, as this will aid in providing appropriate treatment.